[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 73, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2024, "totalPay": 748600, "exercisedValue": 0, "unexercisedValue": 809000}, {"maxAge": 1, "name": "Mr. Andrew  Walsh", "age": 35, "title": "Principal Financial Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen M.B.A.", "title": "Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.85, "open": 2.89, "dayLow": 2.77, "dayHigh": 3.0, "regularMarketPreviousClose": 2.85, "regularMarketOpen": 2.89, "regularMarketDayLow": 2.77, "regularMarketDayHigh": 3.0, "payoutRatio": 0.0, "beta": 1.563, "forwardPE": -1.5966852, "volume": 444898, "regularMarketVolume": 444898, "averageVolume": 453237, "averageVolume10days": 335100, "averageDailyVolume10Day": 335100, "bid": 2.9, "ask": 2.95, "bidSize": 8, "askSize": 7, "marketCap": 56315120, "fiftyTwoWeekLow": 1.11, "fiftyTwoWeekHigh": 11.29, "fiftyDayAverage": 2.5316, "twoHundredDayAverage": 3.91955, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 34079032, "profitMargins": 0.0, "floatShares": 15624645, "sharesOutstanding": 19486200, "sharesShort": 2460828, "sharesShortPriorMonth": 2205405, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1263, "heldPercentInsiders": 0.14685, "heldPercentInstitutions": 0.16099001, "shortRatio": 5.65, "shortPercentOfFloat": 0.14729999, "impliedSharesOutstanding": 19486200, "bookValue": 1.234, "priceToBook": 2.3419774, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -29060496, "trailingEps": -2.24, "forwardEps": -1.81, "52WeekChange": -0.7268431, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 2.89, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.25, "targetMedianPrice": 14.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 22236176, "totalCashPerShare": 1.141, "totalDebt": 0, "quickRatio": 8.879, "currentRatio": 10.676, "returnOnAssets": -0.91054, "returnOnEquity": -2.8078, "freeCashflow": -13948384, "operatingCashflow": -22961016, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Annovis Bio, Inc.", "corporateActions": [], "postMarketTime": 1753487760, "regularMarketTime": 1753473602, "exchange": "NYQ", "messageBoardId": "finmb_622711087", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.40352, "regularMarketPrice": 2.89, "longName": "Annovis Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580308200000, "marketState": "CLOSED", "postMarketChangePercent": 1.3840817, "postMarketPrice": 2.93, "postMarketChange": 0.03999996, "regularMarketChange": 0.0400002, "regularMarketDayRange": "2.77 - 3.0", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 453237, "fiftyTwoWeekLowChange": 1.7800001, "fiftyTwoWeekLowChangePercent": 1.6036037, "fiftyTwoWeekRange": "1.11 - 11.29", "fiftyTwoWeekHighChange": -8.4, "fiftyTwoWeekHighChangePercent": -0.74402124, "fiftyTwoWeekChangePercent": -72.68431, "earningsTimestamp": 1747168200, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.24, "epsForward": -1.81, "epsCurrentYear": -1.09, "priceEpsCurrentYear": -2.6513762, "fiftyDayAverageChange": 0.3584001, "fiftyDayAverageChangePercent": 0.14157058, "twoHundredDayAverageChange": -1.0295498, "twoHundredDayAverageChangePercent": -0.26267043, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Annovis Bio", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]